Subscribe To
ARWR / Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2022 Earnings Call Transcript
Content Topics
Arrowhead
Pharmaceuticals
Inc
ARWR
2022
Earnings
Call
Pharmaceuticals
arwr
Transcript
Stock
ARWR News
By Seeking Alpha
June 6, 2023
Arrowhead: Biotech Innovation On Display
Arrowhead is a promising biotech company with a strong platform and pipeline of drugs targeting various diseases. Arrowhead has expanded its focus fro more_horizontal
By Seeking Alpha
May 2, 2023
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2023 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vice Pr more_horizontal
By Proactive Investors
April 25, 2023
Arrowhead Pharmaceuticals shares rise on positive interim trial results
Arrowhead Pharmaceuticals has released positive interim results from its Phase 1/2 study of its investigational therapeutic ARO-RAGE for inflammatory more_horizontal
By Business Wire
April 18, 2023
Arrowhead Pharmaceuticals to Webcast Fiscal 2023 Second Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference more_horizontal
By The Motley Fool
April 16, 2023
Is Arrowhead Pharmaceuticals a Buy Now?
Arrowhead Pharmaceuticals recently received a rating upgrade from SVB Financial and a price target that implies a 44% gain up ahead. Arrowhead Pharmac more_horizontal
By Business Wire
March 3, 2023
Arrowhead Pharmaceuticals to Present at 43rd Annual Cowen Health Care Conference
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the more_horizontal
By Seeking Alpha
February 23, 2023
Arrowhead Pharmaceuticals Requires Caution
Arrowhead Pharmaceuticals, Inc. is a company with strong potential. However, it has yet to conclusively prove the worth of any part of its vast pipeli more_horizontal
By 24/7 Wall Street
February 13, 2023
Here Are the 5 Best- and Worst-Performing Mid-Cap Stocks in January 2023
For many investors, investing in mid-cap stocks is considered to be a safe portfolio diversification strategy because mid-caps can offer better return more_horizontal